华纳药厂
(688799)
| 流通市值：38.78亿 | | | 总市值：38.78亿 |
| 流通股本：9380.00万 | | | 总股本：9380.00万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 118,093,720.86 | 306,342,845.47 | 461,506,280.89 | 379,645,130.14 |
| 应收票据及应收账款 | 182,617,711.64 | 205,955,821.16 | 190,460,939.64 | 165,668,121.63 |
| 其中：应收票据 | 20,184,305.39 | 13,240,012.82 | 11,635,613.7 | 9,513,748.69 |
| 应收账款 | 162,433,406.25 | 192,715,808.34 | 178,825,325.94 | 156,154,372.94 |
| 应收款项融资 | 22,663,986.88 | 25,400,559.38 | 25,024,068.77 | 17,876,745.17 |
| 预付款项 | 25,407,635.76 | 18,854,556.15 | 12,108,874.67 | 15,030,836.71 |
| 其他应收款合计 | 2,654,496.44 | 2,158,077.21 | 2,381,159.52 | 2,136,203.93 |
| 存货 | 422,735,855.98 | 400,169,134.13 | 368,477,153.49 | 362,668,425.75 |
| 其他流动资产 | 470,451,803.8 | 474,973,898.94 | 351,716,672.46 | 391,721,973.16 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,476,625,211.36 | 1,438,854,892.44 | 1,411,675,149.44 | 1,349,747,436.49 |
| 非流动资产: | | | | |
| 长期股权投资 | 56,499,072.56 | 63,687,110.27 | 54,982,127.38 | 47,145,534.49 |
| 投资性房地产 | 5,789,044.01 | 5,831,193.17 | 5,873,342.33 | 5,915,491.49 |
| 固定资产 | 557,487,981.54 | 562,707,082.17 | 554,614,902.02 | 569,152,819.04 |
| 在建工程 | 90,984,840.34 | 86,868,585.74 | 63,204,951.45 | 27,623,590.52 |
| 无形资产 | 75,035,431.36 | 74,683,536.65 | 75,555,972.99 | 76,623,786.69 |
| 商誉 | 32,381,982.12 | 32,381,982.12 | 32,381,982.12 | 32,381,982.12 |
| 长期待摊费用 | 6,354,624.95 | 4,860,897.22 | 5,214,698.99 | 5,323,610.55 |
| 递延所得税资产 | 22,453,191.06 | 22,314,671.28 | 19,380,515.65 | 18,734,209.95 |
| 其他非流动资产 | 56,361,349.69 | 36,400,596.68 | 43,515,606.95 | 44,294,434.45 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 903,347,517.63 | 889,735,655.3 | 854,724,099.88 | 827,195,459.3 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,379,972,728.99 | 2,328,590,547.74 | 2,266,399,249.32 | 2,176,942,895.79 |
| 流动负债: | | | | |
| 短期借款 | 1,122,542.54 | - | - | - |
| 应付票据及应付账款 | 141,902,548.04 | 141,761,358.74 | 102,622,265.53 | 89,499,035.18 |
| 其中：应付票据 | 22,359,369.21 | 10,000,000 | - | - |
| 应付账款 | 119,543,178.83 | 131,761,358.74 | 102,622,265.53 | 89,499,035.18 |
| 预收款项 | 10,498,840.9 | 7,764,710.05 | 5,046,272.78 | 4,014,020.62 |
| 合同负债 | 74,029,898.93 | 75,161,200.45 | 70,770,153.97 | 76,112,961.74 |
| 应付职工薪酬 | 11,944,575.65 | 11,830,297.23 | 15,050,337.33 | 19,217,156.98 |
| 应交税费 | 6,918,751.48 | 20,753,686.29 | 20,673,494.73 | 17,873,539.31 |
| 其他应付款合计 | 64,295,637.97 | 69,061,735.43 | 118,803,785.31 | 118,161,616.73 |
| 一年内到期的非流动负债 | 62,579.07 | 48,864.32 | 36,187.52 | 13,685.1 |
| 其他流动负债 | 20,177,162.95 | 12,485,852.12 | 11,887,591.41 | 11,484,990 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 330,952,537.53 | 338,867,704.63 | 344,890,088.58 | 336,377,005.66 |
| 非流动负债: | | | | |
| 长期借款 | 90,809,888 | 69,855,888 | 46,945,036 | 17,106,380 |
| 预计负债 | 5,282,000 | 5,282,000 | 5,282,000 | 5,282,000 |
| 递延收益 | 45,353,000.34 | 46,881,650.94 | 48,410,301.54 | 49,938,952.14 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 141,444,888.34 | 122,019,538.94 | 100,637,337.54 | 72,327,332.14 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 472,397,425.87 | 460,887,243.57 | 445,527,426.12 | 408,704,337.8 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 93,800,000 | 93,800,000 | 93,800,000 | 93,800,000 |
| 资本公积 | 850,338,381.88 | 850,338,381.88 | 850,338,381.88 | 850,338,381.88 |
| 盈余公积 | 46,900,000 | 46,900,000 | 46,900,000 | 46,900,000 |
| 未分配利润 | 890,880,306.95 | 845,264,738.99 | 792,524,325.3 | 732,471,267.73 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,881,918,688.83 | 1,836,303,120.87 | 1,783,562,707.18 | 1,723,509,649.61 |
| 少数股东权益 | 25,656,614.29 | 31,400,183.3 | 37,309,116.02 | 44,728,908.38 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,907,575,303.12 | 1,867,703,304.17 | 1,820,871,823.2 | 1,768,238,557.99 |
| 负债和股东权益合计 | 2,379,972,728.99 | 2,328,590,547.74 | 2,266,399,249.32 | 2,176,942,895.79 |
| 公告日期 | 2024-10-29 | 2024-08-31 | 2024-04-20 | 2024-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |